OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers
X. Lucy, Osvaldo Espin‐Garcia, Philippe L. Bédard, et al.
Thyroid (2022) Vol. 32, Iss. 6, pp. 657-666
Closed Access | Times Cited: 24
X. Lucy, Osvaldo Espin‐Garcia, Philippe L. Bédard, et al.
Thyroid (2022) Vol. 32, Iss. 6, pp. 657-666
Closed Access | Times Cited: 24
Showing 24 citing articles:
A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma
Tahereh Haghzad, Babak Khorsand, S. Adeleh Razavi, et al.
Endocrine (2024)
Closed Access | Times Cited: 9
Tahereh Haghzad, Babak Khorsand, S. Adeleh Razavi, et al.
Endocrine (2024)
Closed Access | Times Cited: 9
Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer
Shannon S. Wu, Eric Lamarre, Anirudh Yalamanchali, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 4, pp. 300-300
Open Access | Times Cited: 19
Shannon S. Wu, Eric Lamarre, Anirudh Yalamanchali, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 4, pp. 300-300
Open Access | Times Cited: 19
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Özgür Mete, Andrée Boucher, Kasmintan A. Schrader, et al.
Endocrine Pathology (2024)
Open Access | Times Cited: 7
Özgür Mete, Andrée Boucher, Kasmintan A. Schrader, et al.
Endocrine Pathology (2024)
Open Access | Times Cited: 7
Pathology and new insights in thyroid neoplasms in the 2022 WHO classification
Laetitia Lebrun, Isabelle Salmon
Current Opinion in Oncology (2023) Vol. 36, Iss. 1, pp. 13-21
Open Access | Times Cited: 13
Laetitia Lebrun, Isabelle Salmon
Current Opinion in Oncology (2023) Vol. 36, Iss. 1, pp. 13-21
Open Access | Times Cited: 13
Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches
Srinjan Bhattacharya, Rahul Kumar Mahato, Satwinder Singh, et al.
Life Sciences (2023) Vol. 332, pp. 122110-122110
Open Access | Times Cited: 12
Srinjan Bhattacharya, Rahul Kumar Mahato, Satwinder Singh, et al.
Life Sciences (2023) Vol. 332, pp. 122110-122110
Open Access | Times Cited: 12
Exploration of immunocytochemical biomarkers related to central lymph node metastasis in papillary thyroid microcarcinoma
Lulu Rong, Jie Wang, Qian Wang, et al.
CytoJournal (2025) Vol. 22, pp. 18-18
Open Access
Lulu Rong, Jie Wang, Qian Wang, et al.
CytoJournal (2025) Vol. 22, pp. 18-18
Open Access
Transcriptomic Signatures Specific to Thyroid Cancer Subtypes via Computational Clustering
Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, et al.
Research Square (Research Square) (2025)
Closed Access
Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, et al.
Research Square (Research Square) (2025)
Closed Access
Additional Oncogenic Alterations inRAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Athanasios Bikas, Sara Ahmadi, Θεοδώρα Παππά, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 14, pp. 2678-2685
Open Access | Times Cited: 10
Athanasios Bikas, Sara Ahmadi, Θεοδώρα Παππά, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 14, pp. 2678-2685
Open Access | Times Cited: 10
Allele frequency in thyroid cancer: mechanisms, challenges, and applications in cancer therapy
Jiayu Huang, Jiazhi Wang, Guangzhi Wang, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Jiayu Huang, Jiazhi Wang, Guangzhi Wang, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma
Chan Kwon Jung, Shipra Agarwal, Jen‐Fan Hang, et al.
Endocrine Pathology (2023) Vol. 34, Iss. 1, pp. 1-22
Closed Access | Times Cited: 8
Chan Kwon Jung, Shipra Agarwal, Jen‐Fan Hang, et al.
Endocrine Pathology (2023) Vol. 34, Iss. 1, pp. 1-22
Closed Access | Times Cited: 8
Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea
Han-Sang Baek, Jeonghoon Ha, Seunggyun Ha, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 3020-3031
Open Access | Times Cited: 7
Han-Sang Baek, Jeonghoon Ha, Seunggyun Ha, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 3020-3031
Open Access | Times Cited: 7
MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives
Katerina Saltiki, George Simeakis, Olga Karapanou, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 3, pp. R53-R63
Open Access | Times Cited: 11
Katerina Saltiki, George Simeakis, Olga Karapanou, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 3, pp. R53-R63
Open Access | Times Cited: 11
The Role of Molecular Markers in Thyroid Cancer Diagnostics and Treatment
Alaa Sada, Linwah Yip
Surgical Clinics of North America (2024) Vol. 104, Iss. 4, pp. 741-749
Closed Access | Times Cited: 2
Alaa Sada, Linwah Yip
Surgical Clinics of North America (2024) Vol. 104, Iss. 4, pp. 741-749
Closed Access | Times Cited: 2
Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma
Yongsheng Huang, Peiliang Lin, Jianwei Liao, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Yongsheng Huang, Peiliang Lin, Jianwei Liao, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer
Zhuanzhuan Mu, Xin Zhang, Di Sun, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 5, pp. 1231-1240
Open Access | Times Cited: 6
Zhuanzhuan Mu, Xin Zhang, Di Sun, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 5, pp. 1231-1240
Open Access | Times Cited: 6
Survival Outcomes of Advanced Thyroid Cancer Enriched in Brain Metastases Following Treatment With Small Molecule Inhibitors
Shannon S. Wu, Eric Lamarre, Joseph Scharpf, et al.
Endocrine Practice (2023) Vol. 29, Iss. 11, pp. 881-889
Closed Access | Times Cited: 2
Shannon S. Wu, Eric Lamarre, Joseph Scharpf, et al.
Endocrine Practice (2023) Vol. 29, Iss. 11, pp. 881-889
Closed Access | Times Cited: 2
Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets
Xingxing Dong, Yalong Yang, Jinxuan Hou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Xingxing Dong, Yalong Yang, Jinxuan Hou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Targeted Therapy in Thyroid Cancer
Pooja Ramakant, Kul Ranjan Singh, Anand Mishra, et al.
Indian Journal of Endocrine Surgery and Research (2024) Vol. 19, Iss. 1, pp. 30-46
Open Access
Pooja Ramakant, Kul Ranjan Singh, Anand Mishra, et al.
Indian Journal of Endocrine Surgery and Research (2024) Vol. 19, Iss. 1, pp. 30-46
Open Access
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature
Roberta Casalini, Cristina Romei, Raffaele Ciampi, et al.
Endocrine (2024)
Closed Access
Roberta Casalini, Cristina Romei, Raffaele Ciampi, et al.
Endocrine (2024)
Closed Access
Artificial intelligence in personalized medicine: application of genomics to influence therapy decisions
Benjamin Vinarski, Apurva Ramanujam, Romy Paz, et al.
Elsevier eBooks (2024), pp. 77-113
Closed Access
Benjamin Vinarski, Apurva Ramanujam, Romy Paz, et al.
Elsevier eBooks (2024), pp. 77-113
Closed Access
Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer
Leila Shobab, Leonard Wartofsky
Thyroid (2022) Vol. 33, Iss. 2, pp. 138-142
Closed Access | Times Cited: 2
Leila Shobab, Leonard Wartofsky
Thyroid (2022) Vol. 33, Iss. 2, pp. 138-142
Closed Access | Times Cited: 2
Invited commentary: Real-time thyroid nodule care
Sally E. Carty
Surgery (2022) Vol. 173, Iss. 1, pp. 180-182
Closed Access | Times Cited: 1
Sally E. Carty
Surgery (2022) Vol. 173, Iss. 1, pp. 180-182
Closed Access | Times Cited: 1
Histology-based and cytology-based needle sampling for targeted next-generation sequencing in the indeterminate thyroid tumors
Chun‐Nan Chen, Tsung‐Lin Yang
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 8, pp. 3773-3781
Closed Access
Chun‐Nan Chen, Tsung‐Lin Yang
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 8, pp. 3773-3781
Closed Access
Molecular Target Therapy for Pathologists in Advanced Thyroid Carcinoma
Young Shin Song, Young Joo Park
(2023), pp. 697-713
Closed Access
Young Shin Song, Young Joo Park
(2023), pp. 697-713
Closed Access
